Non-interventional Study of Moderate to Severe Inflammatory Bowel Disease in Brazil
Real-world Data of Moderate to Severe Inflammatory Bowel Disease in Brazil: a Non-interventional, Multicenter Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life (RISE BR)
Sponsor: Takeda
This observational or N/A phase trial investigates Inflammatory Bowel Disease and is currently completed. Takeda leads this study, which shows 12 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Mar 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Mar 2020 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Apr 2017 — Mar 2018 [monthly]
Active Not Recruiting NA
-
Mar 2017 — Apr 2017 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting · Phase: PHASE4 → NA
-
Jan 2017 — Mar 2017 [monthly]
Recruiting PHASE4
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Takeda
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Belo Horizonte, Brazil , Botucatu, Brazil , Curitiba, Brazil , Goiânia, Brazil , Juiz de Fora, Brazil , Porto Alegre, Brazil , Ribeirão Preto, Brazil , Rio de Janeiro, Brazil , Salvador, Brazil , Santo André, Brazil and 3 more locations